Abstract
Inflammatory bowel disease (IBD) is a multifactorial disease including both genetic and environmental factors. We compared the diversity of intestinal microbesamong a cohort of IBD patients to study the microbial ecological effects on IBD. Fecal samples from patients were sequenced with next generation sequence technology at 16S rDNA region. With statistical tools, microbial community was investigated at different level. The gut microbial diversity of Crohn’s disease (CD) patients and colonic polyp (CP) patients significantly different from each other. However, the character of ulcerative colitis (UC) patients has of both CD and CP features. The microbial community from IBD patients can be very different (CD patient) or somewhat similar (UC patients) to non-IBD patients. Microbial diversity can be an important etiological factor for IBD clinical phenotype.
This is a preview of subscription content, access via your institution.




References
Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521–533. doi:10.1038/nri1132
Harlan WR, Meyer A, Fisher J (2016) Inflammatory bowel disease: epidemiology, evaluation, treatment, and health maintenance. N C Med J 77:198–201. doi:10.18043/ncm.77.3.198
Burisch J, Munkholm P (2015) The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 50:942–951. doi:10.3109/00365521.2015.1014407
Xiao B, Merlin D (2012) Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert Opin Drug Deliv 9:1393–1407. doi:10.1517/17425247.2012.730517
Halme L, Paavola-Sakki P, Turunen U, Lappalainen M, Farkkila M, Kontula K (2006) Family and twin studies in inflammatory bowel disease. World J Gastroenterol 12:3668–3672. doi:10.3748/wjg.v12.i23.3668
Van Limbergen J, Russell RK, Nimmo ER, Satsangi J (2007) The genetics of inflammatory bowel disease. Am J Gastroenterol 102:2820–2831. doi:10.1111/j.1572-0241.2007.01527.x
Cho JH, Weaver CT (2007) The genetics of inflammatory bowel disease. Gastroenterology 133:1327–1339. doi:10.1053/j.gastro.2007.08.032
Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207–211. doi:10.1038/ng1954
Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D et al (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat Genet 39:830–832. doi:10.1038/ng2061
Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW et al (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39:596–604. doi:10.1038/ng2032
McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, Zody MC, Hall JL, Brant SR, Cho JH et al (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease. Nat Genet 40:1107–1112. doi:10.1038/ng.215
Wellcome Trust Case Control C (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678. doi:10.1038/nature05911
Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D et al (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40:1319–1323. doi:10.1038/ng.221
Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, Achkar JP, Goyette P, Scott R, Xu W et al (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41:216–220. doi:10.1038/ng.275
Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD (2008) Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 4:e1000024. doi:10.1371/journal.pgen.1000024
Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:313–323. doi:10.1038/nri2515
Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577–594. doi:10.1053/j.gastro.2007.11.059
Donaldson GP, Lee SM, Mazmanian SK (2016) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14:20–32. doi:10.1038/nrmicro3552
Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE (2006) Metagenomic analysis of the human distal gut microbiome. Science 312:1355–1359. doi:10.1126/science.1124234
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP et al (2009) A core gut microbiome in obese and lean twins. Nature 457:480–484. doi:10.1038/nature07540
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307:1915–1920. doi:10.1126/science.1104816
Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW (2016) Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 176:38–68. doi:10.1016/j.trsl.2016.04.009
Human Microbiome Project C (2012) A framework for human microbiome research. Nature 486:215–221. doi:10.1038/nature11209
Human Microbiome Project C (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. doi:10.1038/nature11234
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638. doi:10.1126/science.1110591
Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104:13780–13785. doi:10.1073/pnas.0706625104
Eckburg PB, Relman DA (2007) The role of microbes in Crohn’s disease. Clin Infect Dis 44(2):256–262. doi:10.1086/510385
Xenoulis PG, Palculict B, Allenspach K, Steiner JM, Van House AM, Suchodolski JS (2008) Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol Ecol 66:579–589. doi:10.1111/j.1574-6941.2008.00556.x
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105:16731–16736. doi:10.1073/pnas.0804812105
Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148:1258–1270. doi:10.1016/j.cell.2012.01.035
Spor A, Koren O, Ley R (2011) Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 9:279–290. doi:10.1038/nrmicro2540
Perry S, de la Luz Sanchez M, Yang S, Haggerty TD, Hurst P, Perez-Perez G, Parsonnet J (2006) Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis 12:1701–1708. doi:10.3201/eid1211.060086
Dicksved J, Halfvarson J, Rosenquist M, Jarnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK (2008) Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J 2:716–727. doi:10.1038/ismej.2008.37
Acknowledgements
This work was supported by Grants from the Shanghai Municipal Commission of Health and Family Planning (No. 20124011), the Shanghai Municipal Commission of Health and Family Planning (No. 20164Y0153).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Qiu, Z., Yang, H., Rong, L. et al. Targeted Metagenome Based Analyses Show Gut Microbial Diversity of Inflammatory Bowel Disease patients. Indian J Microbiol 57, 307–315 (2017). https://doi.org/10.1007/s12088-017-0652-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-017-0652-6
Keywords
- Microbial diversity
- 16S rDNA
- Inflammatory bowel disease (IBD)
- Statistical analysis